ConductScience.org, home

Paper · 37546410

FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics.

Boraka Ö and 6 others. Front Oncol, 2023. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics. Papers, record 37546410. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37546410

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics.
PubMed
Journal
Front Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.11
iCite
Revised in PubMed
2023-08-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boraka ÖÖykü
2Klintman MMarie
3Vallon-Christersson JJohan
4Zackrisson SSophia
5Hall PPer
6Borgquist SSigne
7Rosendahl AHAnn H

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130,196,303FGF18 Enhances Migration and the Epithelial-Mesenchymal Transition in Breast Cancer by Regulating Akt/GSK3β/Β-Catenin Signaling.Cell Physiol Biochem2018https://conductscience.org/library/papers/30196303PubMed
228,131,457BI-RADS® fifth edition: A summary of changes.Diagn Interv Imaging2017https://conductscience.org/library/papers/28131457PubMed
317,397,528FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.Breast Cancer Res2007https://conductscience.org/library/papers/17397528PubMed
433,753,561FGFR1 copy number in breast cancer: associations with proliferation, histopathological grade and molecular subtypes.J Clin Pathol2022https://conductscience.org/library/papers/33753561PubMed
529,392,583A comprehensive tool for measuring mammographic density changes over time.Breast Cancer Res Treat2018https://conductscience.org/library/papers/29392583PubMed
616,106,245REporting recommendations for tumour MARKer prognostic studies (REMARK).Br J Cancer2005https://conductscience.org/library/papers/16106245PubMed
717,229,950Mammographic density and the risk and detection of breast cancer.N Engl J Med2007https://conductscience.org/library/papers/17229950PubMed
833,033,110Extracellular Matrix-Bound FGF2 Mediates Estrogen Receptor Signaling and Therapeutic Response in Breast Cancer.Mol Cancer Res2021https://conductscience.org/library/papers/33033110PubMed
936,637,153Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six-arm placebo-controlled trial in healthy women.Int J Cancer2023https://conductscience.org/library/papers/36637153PubMed
1031,032,883Risk-reducing medications for primary breast cancer: a network meta-analysis.Cochrane Database Syst Rev2019https://conductscience.org/library/papers/31032883PubMed

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42,939,589The Impact of FGF Expression in Breast Cancer.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42939589PubMed
40,547,805Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy.Explor Target Antitumor Ther2025https://conductscience.org/library/papers/40547805PubMed

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37546410

GET https://conductscience.org/api/papers/v1/37546410/references?page=2